Patients with undiagnosed chronic obstructive pulmonary disease (COPD) can sometimes hide in plain sight.
1 Sep 2022
CHA2DS2-VASc modestly predicts ischemic stroke, thromboembolism, death in heart failure patients with and without afib
The poor prognosis of atrial fibrillation for ischemic stroke and death in patients with heart failure was evident, but the observation that additional risk factors in patients with heart failure are particularly significant among those without atrial fibrillation is an important result, authors noted.
1 Sep 2015
The authors described the reduced anxiety and fatigue, improved social functioning, and better health-related quality of life as especially encouraging results in light of the negative findings of other trials.
6 Oct 2015
Nine interventions for transitions of care in heart failure may assist in achieving optimal clinical and patient-centered outcomes, according to a scientific statement that addressed patient, hospital, and clinician barriers.
27 Jan 2015
An industry-funded study of patients ages 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
4 Apr 2023
Anticoagulation for heart failure and afib associated with reductions in mortality, but maybe not readmissions
Starting anticoagulation for older patients with heart failure and atrial fibrillation at hospital discharge was associated with improved mortality at 1 and 3 years but was not associated with improved rates of all-cause cardiovascular readmission or stroke, a study found.
16 Sep 2014
Beta-blockers in heart failure patients with preserved ejection fraction may lower all-cause mortality
Use of beta-blockers in patients with heart failure with preserved ejection fraction (HFPEF) was associated with lower all-cause mortality but not with consistent reductions in the combined outcome of mortality and heart failure hospitalization, an observational cohort study found.
18 Nov 2014
A 19% increased risk for hospital admission for heart failure was found to be associated with any use of NSAIDs in the preceding 14 days versus past use of any NSAIDs. Diclofenac, ibuprofen, indomethacin, ketorolac, naproxen, nimesulide, piroxicam, etoricoxib, and rofecoxib were associated with increased risk for hospital admission.
4 Oct 2016
A new drug that combines a neprilysin inhibitor and an angiotensin-receptor blocker (ARB) reduced deaths and hospitalization for heart failure compared to an angiotensin-converting enzyme (ACE) inhibitor, an industry-funded study reported.
9 Sep 2014
Some transitional care interventions more effective than others for reducing readmissions and mortality following hospitalizations for heart failure
Home-visit programs and multidisciplinary clinics reduced all-cause readmission and mortality for up to 6 months following hospitalizations for heart failure, a meta-analysis found.
3 Jun 2014